FDA May Ease Warning on Hormone Therapy for Menopause Symptoms

FDA

Key Takeaways

  • The U.S. Food and Drug Administration is considering changes to a 20-year-old warning on menopause hormone therapy

  • Experts say the warning has discouraged safe use of treatment for hot flashes, poor sleep and other symptoms

  • Research suggests hormone therapy can be safer and more effective when started earlier in menopause

Originally published on healthday.com, part of the BLOX Digital Content Exchange.